JBC:发现促进人类视网膜色素上皮细胞分化的miRNAs

2012-04-25 Deepblue 生物谷

视网膜色素上皮细胞(RPE)与视觉功能的维持息息相关,而RPE的去分化会导致几种增生性眼部疾病。 为了鉴定与RPE分化有关的microRNAs (miRNAs),近日托马斯杰弗逊大学的研究人员比较了已分化的初级人类胚胎RPE(hfRPE)细胞与去分化的hfRPE细胞的miRNA表达图谱。 研究发现,miR-204/211是RPE中两种高表达的miRNAs,它们在去分化的hfRPE细胞中被显著下

视网膜色素上皮细胞(RPE)与视觉功能的维持息息相关,而RPE的去分化会导致几种增生性眼部疾病。

为了鉴定与RPE分化有关的microRNAs (miRNAs),近日托马斯杰弗逊大学的研究人员比较了已分化的初级人类胚胎RPE(hfRPE)细胞与去分化的hfRPE细胞的miRNA表达图谱。

研究发现,miR-204/211是RPE中两种高表达的miRNAs,它们在去分化的hfRPE细胞中被显著下调。

重要的是,把pre-miR-204/211转染进hfRPE细胞会促进RPE分化,而加入miR-204/211抑制剂后会导致它们的去分化。

小眼畸形有关转录因子(MITF)是RPE分化一个主要的调节因子,它在去分化的hfRPE细胞中被下调。MITF的敲除会减少miR-204/211的表达,并引起hfRPE去分化。

值得注意的是,联合转染MITF siRNA与miR-204/211能够恢复RPE表型。

总的说来,这些数据表明miR-204/211能够促进RPE分化,那么miR-204/211很可能会成为与RPE去分化有关疾病(比如增生性玻璃体视网膜病变)的治疗靶点。相关论文发表在4月20日的The Journal of Biological Chemistry。(生物谷Deepblue编译)

doi: 10.1074/jbc.M112.354761
PMC:
PMID:

Microphthalmia-associated transcription factor (MITF) promotes differentiation of human retinal pigment epithelium (RPE) by regulating microRNA-204/211 expression

Jeffrey Adijanto, John J. Castorino, Zi-Xuan Wang, Arvydas Maminishkis, Gerald B. Grunwald and Nancy J. Philp.

The retinal pigment epithelium (RPE) plays a fundamental role in maintaining visual function and dedifferentiation of RPE contributes to the pathophysiology of several proliferative ocular diseases.To identify microRNAs (miRNAs) that may be involved in RPE differentiation, we compared the miRNA expression profiles of differentiated primary human fetal RPE (hfRPE) cells to dedifferentiated hfRPE cells. We found that miR-204/211, the two most highly expressed miRNAs in the RPE, were significantly downregulated in dedifferentiated hfRPE cells.Importantly, transfection of pre-miR-204/211 into hfRPE cells promoted differentiation whereas adding miR-204/211 inhibitors led to their dedifferentiation.Microphthalmia-associated transcription factor (MITF) is a key regulator of RPE differentiation that was also downregulated in dedifferentiated hfRPE cells.MITF-knockdown decreased miR-204/211 expression and caused hfRPE dedifferentiation. Significantly, co-transfection of MITF siRNA with miR-204/211 mimics rescued RPE phenotype. Collectively, our data show that miR-204/211 promote RPE differentiation, suggesting that miR-204/211-based therapeutics may be effective treatments for diseases that involve RPE dedifferentation such as proliferative vitreoretinopathy.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1810976, encodeId=faf018109e6cc, content=<a href='/topic/show?id=560e86e092b' target=_blank style='color:#2F92EE;'>#色素上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86709, encryptionId=560e86e092b, topicName=色素上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570f404, createdName=xlxchina, createdTime=Sat Jun 02 10:17:00 CST 2012, time=2012-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005402, encodeId=8f8b2005402a8, content=<a href='/topic/show?id=d09f155461e' target=_blank style='color:#2F92EE;'>#RNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15546, encryptionId=d09f155461e, topicName=RNAs)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Sat May 05 16:17:00 CST 2012, time=2012-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036357, encodeId=5903203635eeb, content=<a href='/topic/show?id=0c901025932' target=_blank style='color:#2F92EE;'>#JBC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10259, encryptionId=0c901025932, topicName=JBC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Tue Jul 31 18:17:00 CST 2012, time=2012-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680193, encodeId=df2716801939b, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Sun Aug 19 16:17:00 CST 2012, time=2012-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930349, encodeId=84ee1930349ef, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Wed Aug 22 10:17:00 CST 2012, time=2012-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810945, encodeId=7af8181094580, content=<a href='/topic/show?id=bf4486e08be' target=_blank style='color:#2F92EE;'>#色素上皮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86708, encryptionId=bf4486e08be, topicName=色素上皮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73a3403, createdName=weihongyv, createdTime=Mon Sep 03 15:17:00 CST 2012, time=2012-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269768, encodeId=6eeb1269e6825, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312240, encodeId=1a6913122409d, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533803, encodeId=fb2115338031a, content=<a href='/topic/show?id=4be9200308c' target=_blank style='color:#2F92EE;'>#上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20030, encryptionId=4be9200308c, topicName=上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a5d12492718, createdName=lizhou0208, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568409, encodeId=c2e6156840957, content=<a href='/topic/show?id=9fec9080901' target=_blank style='color:#2F92EE;'>#视网膜色素上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90809, encryptionId=9fec9080901, topicName=视网膜色素上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1be15374853, createdName=wetgdt, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1810976, encodeId=faf018109e6cc, content=<a href='/topic/show?id=560e86e092b' target=_blank style='color:#2F92EE;'>#色素上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86709, encryptionId=560e86e092b, topicName=色素上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570f404, createdName=xlxchina, createdTime=Sat Jun 02 10:17:00 CST 2012, time=2012-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005402, encodeId=8f8b2005402a8, content=<a href='/topic/show?id=d09f155461e' target=_blank style='color:#2F92EE;'>#RNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15546, encryptionId=d09f155461e, topicName=RNAs)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Sat May 05 16:17:00 CST 2012, time=2012-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036357, encodeId=5903203635eeb, content=<a href='/topic/show?id=0c901025932' target=_blank style='color:#2F92EE;'>#JBC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10259, encryptionId=0c901025932, topicName=JBC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Tue Jul 31 18:17:00 CST 2012, time=2012-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680193, encodeId=df2716801939b, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Sun Aug 19 16:17:00 CST 2012, time=2012-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930349, encodeId=84ee1930349ef, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Wed Aug 22 10:17:00 CST 2012, time=2012-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810945, encodeId=7af8181094580, content=<a href='/topic/show?id=bf4486e08be' target=_blank style='color:#2F92EE;'>#色素上皮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86708, encryptionId=bf4486e08be, topicName=色素上皮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73a3403, createdName=weihongyv, createdTime=Mon Sep 03 15:17:00 CST 2012, time=2012-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269768, encodeId=6eeb1269e6825, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312240, encodeId=1a6913122409d, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533803, encodeId=fb2115338031a, content=<a href='/topic/show?id=4be9200308c' target=_blank style='color:#2F92EE;'>#上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20030, encryptionId=4be9200308c, topicName=上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a5d12492718, createdName=lizhou0208, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568409, encodeId=c2e6156840957, content=<a href='/topic/show?id=9fec9080901' target=_blank style='color:#2F92EE;'>#视网膜色素上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90809, encryptionId=9fec9080901, topicName=视网膜色素上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1be15374853, createdName=wetgdt, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=)]
    2012-05-05 dzx0922889
  3. [GetPortalCommentsPageByObjectIdResponse(id=1810976, encodeId=faf018109e6cc, content=<a href='/topic/show?id=560e86e092b' target=_blank style='color:#2F92EE;'>#色素上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86709, encryptionId=560e86e092b, topicName=色素上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570f404, createdName=xlxchina, createdTime=Sat Jun 02 10:17:00 CST 2012, time=2012-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005402, encodeId=8f8b2005402a8, content=<a href='/topic/show?id=d09f155461e' target=_blank style='color:#2F92EE;'>#RNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15546, encryptionId=d09f155461e, topicName=RNAs)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Sat May 05 16:17:00 CST 2012, time=2012-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036357, encodeId=5903203635eeb, content=<a href='/topic/show?id=0c901025932' target=_blank style='color:#2F92EE;'>#JBC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10259, encryptionId=0c901025932, topicName=JBC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Tue Jul 31 18:17:00 CST 2012, time=2012-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680193, encodeId=df2716801939b, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Sun Aug 19 16:17:00 CST 2012, time=2012-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930349, encodeId=84ee1930349ef, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Wed Aug 22 10:17:00 CST 2012, time=2012-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810945, encodeId=7af8181094580, content=<a href='/topic/show?id=bf4486e08be' target=_blank style='color:#2F92EE;'>#色素上皮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86708, encryptionId=bf4486e08be, topicName=色素上皮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73a3403, createdName=weihongyv, createdTime=Mon Sep 03 15:17:00 CST 2012, time=2012-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269768, encodeId=6eeb1269e6825, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312240, encodeId=1a6913122409d, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533803, encodeId=fb2115338031a, content=<a href='/topic/show?id=4be9200308c' target=_blank style='color:#2F92EE;'>#上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20030, encryptionId=4be9200308c, topicName=上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a5d12492718, createdName=lizhou0208, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568409, encodeId=c2e6156840957, content=<a href='/topic/show?id=9fec9080901' target=_blank style='color:#2F92EE;'>#视网膜色素上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90809, encryptionId=9fec9080901, topicName=视网膜色素上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1be15374853, createdName=wetgdt, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=)]
    2012-07-31 lily1616
  4. [GetPortalCommentsPageByObjectIdResponse(id=1810976, encodeId=faf018109e6cc, content=<a href='/topic/show?id=560e86e092b' target=_blank style='color:#2F92EE;'>#色素上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86709, encryptionId=560e86e092b, topicName=色素上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570f404, createdName=xlxchina, createdTime=Sat Jun 02 10:17:00 CST 2012, time=2012-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005402, encodeId=8f8b2005402a8, content=<a href='/topic/show?id=d09f155461e' target=_blank style='color:#2F92EE;'>#RNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15546, encryptionId=d09f155461e, topicName=RNAs)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Sat May 05 16:17:00 CST 2012, time=2012-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036357, encodeId=5903203635eeb, content=<a href='/topic/show?id=0c901025932' target=_blank style='color:#2F92EE;'>#JBC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10259, encryptionId=0c901025932, topicName=JBC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Tue Jul 31 18:17:00 CST 2012, time=2012-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680193, encodeId=df2716801939b, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Sun Aug 19 16:17:00 CST 2012, time=2012-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930349, encodeId=84ee1930349ef, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Wed Aug 22 10:17:00 CST 2012, time=2012-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810945, encodeId=7af8181094580, content=<a href='/topic/show?id=bf4486e08be' target=_blank style='color:#2F92EE;'>#色素上皮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86708, encryptionId=bf4486e08be, topicName=色素上皮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73a3403, createdName=weihongyv, createdTime=Mon Sep 03 15:17:00 CST 2012, time=2012-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269768, encodeId=6eeb1269e6825, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312240, encodeId=1a6913122409d, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533803, encodeId=fb2115338031a, content=<a href='/topic/show?id=4be9200308c' target=_blank style='color:#2F92EE;'>#上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20030, encryptionId=4be9200308c, topicName=上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a5d12492718, createdName=lizhou0208, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568409, encodeId=c2e6156840957, content=<a href='/topic/show?id=9fec9080901' target=_blank style='color:#2F92EE;'>#视网膜色素上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90809, encryptionId=9fec9080901, topicName=视网膜色素上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1be15374853, createdName=wetgdt, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=)]
    2012-08-19 sunylz
  5. [GetPortalCommentsPageByObjectIdResponse(id=1810976, encodeId=faf018109e6cc, content=<a href='/topic/show?id=560e86e092b' target=_blank style='color:#2F92EE;'>#色素上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86709, encryptionId=560e86e092b, topicName=色素上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570f404, createdName=xlxchina, createdTime=Sat Jun 02 10:17:00 CST 2012, time=2012-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005402, encodeId=8f8b2005402a8, content=<a href='/topic/show?id=d09f155461e' target=_blank style='color:#2F92EE;'>#RNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15546, encryptionId=d09f155461e, topicName=RNAs)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Sat May 05 16:17:00 CST 2012, time=2012-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036357, encodeId=5903203635eeb, content=<a href='/topic/show?id=0c901025932' target=_blank style='color:#2F92EE;'>#JBC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10259, encryptionId=0c901025932, topicName=JBC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Tue Jul 31 18:17:00 CST 2012, time=2012-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680193, encodeId=df2716801939b, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Sun Aug 19 16:17:00 CST 2012, time=2012-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930349, encodeId=84ee1930349ef, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Wed Aug 22 10:17:00 CST 2012, time=2012-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810945, encodeId=7af8181094580, content=<a href='/topic/show?id=bf4486e08be' target=_blank style='color:#2F92EE;'>#色素上皮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86708, encryptionId=bf4486e08be, topicName=色素上皮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73a3403, createdName=weihongyv, createdTime=Mon Sep 03 15:17:00 CST 2012, time=2012-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269768, encodeId=6eeb1269e6825, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312240, encodeId=1a6913122409d, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533803, encodeId=fb2115338031a, content=<a href='/topic/show?id=4be9200308c' target=_blank style='color:#2F92EE;'>#上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20030, encryptionId=4be9200308c, topicName=上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a5d12492718, createdName=lizhou0208, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568409, encodeId=c2e6156840957, content=<a href='/topic/show?id=9fec9080901' target=_blank style='color:#2F92EE;'>#视网膜色素上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90809, encryptionId=9fec9080901, topicName=视网膜色素上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1be15374853, createdName=wetgdt, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=)]
    2012-08-22 smallant2002
  6. [GetPortalCommentsPageByObjectIdResponse(id=1810976, encodeId=faf018109e6cc, content=<a href='/topic/show?id=560e86e092b' target=_blank style='color:#2F92EE;'>#色素上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86709, encryptionId=560e86e092b, topicName=色素上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570f404, createdName=xlxchina, createdTime=Sat Jun 02 10:17:00 CST 2012, time=2012-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005402, encodeId=8f8b2005402a8, content=<a href='/topic/show?id=d09f155461e' target=_blank style='color:#2F92EE;'>#RNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15546, encryptionId=d09f155461e, topicName=RNAs)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Sat May 05 16:17:00 CST 2012, time=2012-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036357, encodeId=5903203635eeb, content=<a href='/topic/show?id=0c901025932' target=_blank style='color:#2F92EE;'>#JBC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10259, encryptionId=0c901025932, topicName=JBC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Tue Jul 31 18:17:00 CST 2012, time=2012-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680193, encodeId=df2716801939b, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Sun Aug 19 16:17:00 CST 2012, time=2012-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930349, encodeId=84ee1930349ef, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Wed Aug 22 10:17:00 CST 2012, time=2012-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810945, encodeId=7af8181094580, content=<a href='/topic/show?id=bf4486e08be' target=_blank style='color:#2F92EE;'>#色素上皮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86708, encryptionId=bf4486e08be, topicName=色素上皮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73a3403, createdName=weihongyv, createdTime=Mon Sep 03 15:17:00 CST 2012, time=2012-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269768, encodeId=6eeb1269e6825, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312240, encodeId=1a6913122409d, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533803, encodeId=fb2115338031a, content=<a href='/topic/show?id=4be9200308c' target=_blank style='color:#2F92EE;'>#上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20030, encryptionId=4be9200308c, topicName=上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a5d12492718, createdName=lizhou0208, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568409, encodeId=c2e6156840957, content=<a href='/topic/show?id=9fec9080901' target=_blank style='color:#2F92EE;'>#视网膜色素上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90809, encryptionId=9fec9080901, topicName=视网膜色素上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1be15374853, createdName=wetgdt, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1810976, encodeId=faf018109e6cc, content=<a href='/topic/show?id=560e86e092b' target=_blank style='color:#2F92EE;'>#色素上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86709, encryptionId=560e86e092b, topicName=色素上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570f404, createdName=xlxchina, createdTime=Sat Jun 02 10:17:00 CST 2012, time=2012-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005402, encodeId=8f8b2005402a8, content=<a href='/topic/show?id=d09f155461e' target=_blank style='color:#2F92EE;'>#RNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15546, encryptionId=d09f155461e, topicName=RNAs)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Sat May 05 16:17:00 CST 2012, time=2012-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036357, encodeId=5903203635eeb, content=<a href='/topic/show?id=0c901025932' target=_blank style='color:#2F92EE;'>#JBC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10259, encryptionId=0c901025932, topicName=JBC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Tue Jul 31 18:17:00 CST 2012, time=2012-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680193, encodeId=df2716801939b, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Sun Aug 19 16:17:00 CST 2012, time=2012-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930349, encodeId=84ee1930349ef, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Wed Aug 22 10:17:00 CST 2012, time=2012-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810945, encodeId=7af8181094580, content=<a href='/topic/show?id=bf4486e08be' target=_blank style='color:#2F92EE;'>#色素上皮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86708, encryptionId=bf4486e08be, topicName=色素上皮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73a3403, createdName=weihongyv, createdTime=Mon Sep 03 15:17:00 CST 2012, time=2012-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269768, encodeId=6eeb1269e6825, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312240, encodeId=1a6913122409d, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533803, encodeId=fb2115338031a, content=<a href='/topic/show?id=4be9200308c' target=_blank style='color:#2F92EE;'>#上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20030, encryptionId=4be9200308c, topicName=上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a5d12492718, createdName=lizhou0208, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568409, encodeId=c2e6156840957, content=<a href='/topic/show?id=9fec9080901' target=_blank style='color:#2F92EE;'>#视网膜色素上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90809, encryptionId=9fec9080901, topicName=视网膜色素上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1be15374853, createdName=wetgdt, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=)]
    2012-04-27 zutt
  8. [GetPortalCommentsPageByObjectIdResponse(id=1810976, encodeId=faf018109e6cc, content=<a href='/topic/show?id=560e86e092b' target=_blank style='color:#2F92EE;'>#色素上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86709, encryptionId=560e86e092b, topicName=色素上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570f404, createdName=xlxchina, createdTime=Sat Jun 02 10:17:00 CST 2012, time=2012-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005402, encodeId=8f8b2005402a8, content=<a href='/topic/show?id=d09f155461e' target=_blank style='color:#2F92EE;'>#RNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15546, encryptionId=d09f155461e, topicName=RNAs)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Sat May 05 16:17:00 CST 2012, time=2012-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036357, encodeId=5903203635eeb, content=<a href='/topic/show?id=0c901025932' target=_blank style='color:#2F92EE;'>#JBC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10259, encryptionId=0c901025932, topicName=JBC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Tue Jul 31 18:17:00 CST 2012, time=2012-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680193, encodeId=df2716801939b, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Sun Aug 19 16:17:00 CST 2012, time=2012-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930349, encodeId=84ee1930349ef, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Wed Aug 22 10:17:00 CST 2012, time=2012-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810945, encodeId=7af8181094580, content=<a href='/topic/show?id=bf4486e08be' target=_blank style='color:#2F92EE;'>#色素上皮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86708, encryptionId=bf4486e08be, topicName=色素上皮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73a3403, createdName=weihongyv, createdTime=Mon Sep 03 15:17:00 CST 2012, time=2012-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269768, encodeId=6eeb1269e6825, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312240, encodeId=1a6913122409d, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533803, encodeId=fb2115338031a, content=<a href='/topic/show?id=4be9200308c' target=_blank style='color:#2F92EE;'>#上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20030, encryptionId=4be9200308c, topicName=上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a5d12492718, createdName=lizhou0208, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568409, encodeId=c2e6156840957, content=<a href='/topic/show?id=9fec9080901' target=_blank style='color:#2F92EE;'>#视网膜色素上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90809, encryptionId=9fec9080901, topicName=视网膜色素上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1be15374853, createdName=wetgdt, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=)]
    2012-04-27 Homburg
  9. [GetPortalCommentsPageByObjectIdResponse(id=1810976, encodeId=faf018109e6cc, content=<a href='/topic/show?id=560e86e092b' target=_blank style='color:#2F92EE;'>#色素上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86709, encryptionId=560e86e092b, topicName=色素上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570f404, createdName=xlxchina, createdTime=Sat Jun 02 10:17:00 CST 2012, time=2012-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005402, encodeId=8f8b2005402a8, content=<a href='/topic/show?id=d09f155461e' target=_blank style='color:#2F92EE;'>#RNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15546, encryptionId=d09f155461e, topicName=RNAs)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Sat May 05 16:17:00 CST 2012, time=2012-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036357, encodeId=5903203635eeb, content=<a href='/topic/show?id=0c901025932' target=_blank style='color:#2F92EE;'>#JBC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10259, encryptionId=0c901025932, topicName=JBC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Tue Jul 31 18:17:00 CST 2012, time=2012-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680193, encodeId=df2716801939b, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Sun Aug 19 16:17:00 CST 2012, time=2012-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930349, encodeId=84ee1930349ef, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Wed Aug 22 10:17:00 CST 2012, time=2012-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810945, encodeId=7af8181094580, content=<a href='/topic/show?id=bf4486e08be' target=_blank style='color:#2F92EE;'>#色素上皮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86708, encryptionId=bf4486e08be, topicName=色素上皮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73a3403, createdName=weihongyv, createdTime=Mon Sep 03 15:17:00 CST 2012, time=2012-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269768, encodeId=6eeb1269e6825, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312240, encodeId=1a6913122409d, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533803, encodeId=fb2115338031a, content=<a href='/topic/show?id=4be9200308c' target=_blank style='color:#2F92EE;'>#上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20030, encryptionId=4be9200308c, topicName=上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a5d12492718, createdName=lizhou0208, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568409, encodeId=c2e6156840957, content=<a href='/topic/show?id=9fec9080901' target=_blank style='color:#2F92EE;'>#视网膜色素上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90809, encryptionId=9fec9080901, topicName=视网膜色素上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1be15374853, createdName=wetgdt, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=)]
  10. [GetPortalCommentsPageByObjectIdResponse(id=1810976, encodeId=faf018109e6cc, content=<a href='/topic/show?id=560e86e092b' target=_blank style='color:#2F92EE;'>#色素上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86709, encryptionId=560e86e092b, topicName=色素上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570f404, createdName=xlxchina, createdTime=Sat Jun 02 10:17:00 CST 2012, time=2012-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005402, encodeId=8f8b2005402a8, content=<a href='/topic/show?id=d09f155461e' target=_blank style='color:#2F92EE;'>#RNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15546, encryptionId=d09f155461e, topicName=RNAs)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Sat May 05 16:17:00 CST 2012, time=2012-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036357, encodeId=5903203635eeb, content=<a href='/topic/show?id=0c901025932' target=_blank style='color:#2F92EE;'>#JBC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10259, encryptionId=0c901025932, topicName=JBC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Tue Jul 31 18:17:00 CST 2012, time=2012-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680193, encodeId=df2716801939b, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Sun Aug 19 16:17:00 CST 2012, time=2012-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930349, encodeId=84ee1930349ef, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Wed Aug 22 10:17:00 CST 2012, time=2012-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810945, encodeId=7af8181094580, content=<a href='/topic/show?id=bf4486e08be' target=_blank style='color:#2F92EE;'>#色素上皮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86708, encryptionId=bf4486e08be, topicName=色素上皮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73a3403, createdName=weihongyv, createdTime=Mon Sep 03 15:17:00 CST 2012, time=2012-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269768, encodeId=6eeb1269e6825, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312240, encodeId=1a6913122409d, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533803, encodeId=fb2115338031a, content=<a href='/topic/show?id=4be9200308c' target=_blank style='color:#2F92EE;'>#上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20030, encryptionId=4be9200308c, topicName=上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a5d12492718, createdName=lizhou0208, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568409, encodeId=c2e6156840957, content=<a href='/topic/show?id=9fec9080901' target=_blank style='color:#2F92EE;'>#视网膜色素上皮细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90809, encryptionId=9fec9080901, topicName=视网膜色素上皮细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1be15374853, createdName=wetgdt, createdTime=Fri Apr 27 02:17:00 CST 2012, time=2012-04-27, status=1, ipAttribution=)]

相关资讯

JCI:维生素D对骨质疏松症的双刃剑作用

维生素D有强筋骨作用,是调节血钙水平的关键。钙主要是通过饮食获得,钙通过肠道吸收进入血流。除了促进骨骼强健外,钙是多种重要生理过程的必需物质。维生素D存在骨和肠细胞受体中,该受体具有调节血液中钙的水平,并决定钙在骨骼中储存多少。最近的几项临床试验研究证实维生素D补充剂对中老年人由预防骨折的功效,然而这些试验的结果并没有对这些补充剂的功效达成一个共识。 在这一月的JCI的杂志上,比利时鲁汶大学Ge

J Neurosci:张志珺等揭示aMCI和RGD发病机制存在关联

近日,国际著名杂志《神经科学期刊》The Journal of Neuroscience以封面文章发表了东南大学附属中大医院等机构的最新研究成果“Topologically Convergent and Divergent Structural Connectivity Patterns between Patients with Remitted Geriatric Depression and

Age and Ageing:违禁药物在英国的使用量将持续增加

A chilled old age (Image: Mark Gibson/Getty Images) 目前,英国新生儿使用违禁药物的量相比父母辈们少的多了,尤其是印度大麻的使用量;在美国也是如此。近日,来自伦敦国王学院的研究者Robert Stewart和他的研究团队研究发现在英国50岁至65岁的老年人中,有11.4%的人曾经使用过印度大麻,而其后代使用印度大麻的比例仅仅为1.7%。 研究者

Diabetes:异种器官移植治疗1型糖尿病

1型糖尿病是由产生胰岛素的β细胞遭到自身免疫性破坏引发。在德国,超过25万患者遭受1型糖尿病影响,患者每天注射胰岛素治疗以保持糖代谢。更换一个完整的胰腺器官或人类β细胞移植是治愈疾病的唯一有效途径。然而由于器官捐赠短缺的缘故,这种方法只可以提供少数患者予以治疗。作为一个替代方法,研究人员正在探索异种器官移植,即从其他物种移植器官。但其中最明显的障碍就是异种移植的免疫排斥反应。 近日,慕尼黑大学的

J IMMUNOL:空气污染与结核易感性间的可能联系

据研究,在常见城市空气污染与重要免疫细胞功能改变之间,可能存在一种相关性,其中免疫细胞是能防御结核分支杆菌(Mycobacterium tuberculosis)的细胞。在流行病学方面,已有证据证明结核病与吸烟及某些室内空气污染有关系,将这种关系类比于室外空气污染看起来是合乎逻辑的。 据估计,全世界约有800-1000万人受结核病折磨,每年造成150万人死亡。在低收入和中等收入国家,结核病发病率

AAC:张云等新型肽类抗生素保护临床耐药菌感染药效学研究获进展

近日,美国著名药理学和药学杂志Antimicrobial Agents and Chemotherapy在线刊登了中科院昆明动物所研究人员的最新研究成果“Efficacy of OH-CATH30 and its analogs against drug-resistant bacteria in vitro and in mouse models ,”,文章中,研究者揭示了他们在新型肽类抗生素体